Showing 761-770 of 1718 results for "".
Remote Work Balances Life
https://practicalneurology.com/columns/practice-management/remote-work-balances-life/30354/Expanding the Scope of Neurology: An Interview with Ralph L. Sacco, MD
https://practicalneurology.com/columns/practice-management/expanding-the-scope-of-neurology-an-interview-with-ralph-l-sacco-md/30358/New AAN President sees collaboration and wellness as integral to the future of the specialty.Exploring Expanded Labeling for DBS for Parkinson's
https://practicalneurology.com/diseases-diagnoses/movement-disorders/exploring-expanded-labeling-for-dbs-for-parkinsons/30694/Expanded labeling is based on data showing an improvement in quality of life and longer-term data.In-Focus: Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/in-focus-movement-disorders/30381/Sleep: In-Focus
https://practicalneurology.com/diseases-diagnoses/sleep/sleep-in-focus/30414/Special Report: A Touching Movement
https://practicalneurology.com/diseases-diagnoses/tbi/special-report-a-touching-movement/30642/A quadriplegic man moved neuromodulation a step forward.Viewpoints Teleneurology Report Card: Proof of Concept
https://practicalneurology.com/columns/practice-management/viewpoints-teleneurology-report-card-proof-of-concept/30806/Teleneurology may be viewed as a “physician extender” not for an individual practitioner, but for the entire specialty, according to one teleneurologist.Alzheimer Disease: Selection and Delivery of Amyloid-Targeting Treatments
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/alzheimer-disease-selection-and-delivery-of-amyloid-targeting-treatments/36237/Modern Glioma Management: Integrating Molecular Markers and New Targeted Therapies
https://practicalneurology.com/diseases-diagnoses/neuro-oncology/modern-glioma-management-integrating-molecular-markers-and-new-targeted-therapies/48967/Patrick Y. Wen, MD, Dana-Farber Cancer Institute, Boston, MA, discusses current standards of care for low- and high-grade gliomas, including the importance of comprehensive molecular testing, the World Health Organization classification of tumors of the central nervous system, and newly available thA Practical Evaluation of Migraine Trigger Site Deactivation Surgery
https://practicalneurology.com/diseases-diagnoses/headache-pain/a-practical-evaluation-of-migraine-trigger-site-deactivation/30696/An analysis of the data casts doubt on the purported benefits of MTSDS.